Cargando…
The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art
SIMPLE SUMMARY: Lung cancer evolutions, innovative systemic treatments, minimally invasive thoracic surgery approaches and perioperative medical care have changed the role of surgery in the treatment of lung cancer. Pre-invasive and early-stage lung cancer, and conversely, advanced and metastatic tu...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345199/ https://www.ncbi.nlm.nih.gov/pubmed/34359612 http://dx.doi.org/10.3390/cancers13153711 |
_version_ | 1783734573333479424 |
---|---|
author | Montagne, François Guisier, Florian Venissac, Nicolas Baste, Jean-Marc |
author_facet | Montagne, François Guisier, Florian Venissac, Nicolas Baste, Jean-Marc |
author_sort | Montagne, François |
collection | PubMed |
description | SIMPLE SUMMARY: Lung cancer evolutions, innovative systemic treatments, minimally invasive thoracic surgery approaches and perioperative medical care have changed the role of surgery in the treatment of lung cancer. Pre-invasive and early-stage lung cancer, and conversely, advanced and metastatic tumors can be treated by innovative imaging-guided resection, minimally invasive approach or hybrid approach with very good short-term outcomes, enhanced recovery and preserved long-term survival. Considering lung cancer as a chronic disease, surgery must anticipate future disease evolution by sparing lung tissue and preserving lung function, while an oncologic complete resection must be performed. Surgery could also be valuable when recurrences occur or for selected palliative conditions. This article outlines present indications and future perspectives of lung surgery in lung cancer. ABSTRACT: Non-small cell lung cancers (NSCLC) are different today, due to the increased use of screening programs and of innovative systemic therapies, leading to the diagnosis of earlier and pre-invasive tumors, and of more advanced and controlled metastatic tumors. Surgery for NSCLC remains the cornerstone treatment when it can be performed. The role of surgery and surgeons has also evolved because surgeons not only perform the initial curative lung cancer resection but they also accompany and follow-up patients from pre-operative rehabilitation, to treatment for recurrences. Surgery is personalized, according to cancer characteristics, including cancer extensions, from pre-invasive and local tumors to locally advanced, metastatic disease, or residual disease after medical treatment, anticipating recurrences, and patients’ characteristics. Surgical management is constantly evolving to offer the best oncologic resection adapted to each NSCLC stage. Today, NSCLC can be considered as a chronic disease and surgery is a valuable tool for the diagnosis and treatment of recurrences, and in palliative conditions to relieve dyspnea and improve patients’ comfort. |
format | Online Article Text |
id | pubmed-8345199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83451992021-08-07 The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art Montagne, François Guisier, Florian Venissac, Nicolas Baste, Jean-Marc Cancers (Basel) Review SIMPLE SUMMARY: Lung cancer evolutions, innovative systemic treatments, minimally invasive thoracic surgery approaches and perioperative medical care have changed the role of surgery in the treatment of lung cancer. Pre-invasive and early-stage lung cancer, and conversely, advanced and metastatic tumors can be treated by innovative imaging-guided resection, minimally invasive approach or hybrid approach with very good short-term outcomes, enhanced recovery and preserved long-term survival. Considering lung cancer as a chronic disease, surgery must anticipate future disease evolution by sparing lung tissue and preserving lung function, while an oncologic complete resection must be performed. Surgery could also be valuable when recurrences occur or for selected palliative conditions. This article outlines present indications and future perspectives of lung surgery in lung cancer. ABSTRACT: Non-small cell lung cancers (NSCLC) are different today, due to the increased use of screening programs and of innovative systemic therapies, leading to the diagnosis of earlier and pre-invasive tumors, and of more advanced and controlled metastatic tumors. Surgery for NSCLC remains the cornerstone treatment when it can be performed. The role of surgery and surgeons has also evolved because surgeons not only perform the initial curative lung cancer resection but they also accompany and follow-up patients from pre-operative rehabilitation, to treatment for recurrences. Surgery is personalized, according to cancer characteristics, including cancer extensions, from pre-invasive and local tumors to locally advanced, metastatic disease, or residual disease after medical treatment, anticipating recurrences, and patients’ characteristics. Surgical management is constantly evolving to offer the best oncologic resection adapted to each NSCLC stage. Today, NSCLC can be considered as a chronic disease and surgery is a valuable tool for the diagnosis and treatment of recurrences, and in palliative conditions to relieve dyspnea and improve patients’ comfort. MDPI 2021-07-23 /pmc/articles/PMC8345199/ /pubmed/34359612 http://dx.doi.org/10.3390/cancers13153711 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Montagne, François Guisier, Florian Venissac, Nicolas Baste, Jean-Marc The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art |
title | The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art |
title_full | The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art |
title_fullStr | The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art |
title_full_unstemmed | The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art |
title_short | The Role of Surgery in Lung Cancer Treatment: Present Indications and Future Perspectives—State of the Art |
title_sort | role of surgery in lung cancer treatment: present indications and future perspectives—state of the art |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345199/ https://www.ncbi.nlm.nih.gov/pubmed/34359612 http://dx.doi.org/10.3390/cancers13153711 |
work_keys_str_mv | AT montagnefrancois theroleofsurgeryinlungcancertreatmentpresentindicationsandfutureperspectivesstateoftheart AT guisierflorian theroleofsurgeryinlungcancertreatmentpresentindicationsandfutureperspectivesstateoftheart AT venissacnicolas theroleofsurgeryinlungcancertreatmentpresentindicationsandfutureperspectivesstateoftheart AT bastejeanmarc theroleofsurgeryinlungcancertreatmentpresentindicationsandfutureperspectivesstateoftheart AT montagnefrancois roleofsurgeryinlungcancertreatmentpresentindicationsandfutureperspectivesstateoftheart AT guisierflorian roleofsurgeryinlungcancertreatmentpresentindicationsandfutureperspectivesstateoftheart AT venissacnicolas roleofsurgeryinlungcancertreatmentpresentindicationsandfutureperspectivesstateoftheart AT bastejeanmarc roleofsurgeryinlungcancertreatmentpresentindicationsandfutureperspectivesstateoftheart |